Estimated annual direct medical costs of manifestations among patients with activated phosphoinositide 3-kinase delta syndrome
Clin Exp Med. 2025 Jul 12;25(1):246. doi: 10.1007/s10238-025-01773-1. ABSTRACT Activated phosphoinositide 3-kinase delta syndrome (APDS) is a rare genetic disease associated with heterogeneous manifestations, including …